InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Civik Thomas, Director. Officer active across 2 companies, notably Repare Therapeutics Inc.. In total, 5 reports have been recorded. Total volume traded: €724k. The latest transaction was disclosed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
066,831 shares0
Common Stock
SEC:0001140361-22-012919:0·
€176,67615,700 shares@ €11.2532100.0% of flow
Common Stock
SEC:0000899243-21-045363·
Ideal exit: 15 Aug 2022 (T+270)
€176,67615,700 shares@ €11.25320.12% mcap50.0% of flow
Common Stock
SEC:0000899243-21-045363:0·
Ideal exit: 15 Aug 2022 (T+270)
€185,2827,500 shares@ €24.7042100.0% of flow
Common Shares
SEC:0001209191-21-065517·
Ideal exit: 13 Aug 2022 (T+270)
€185,2827,500 shares@ €24.704250.0% of flow
Common Shares
SEC:0001209191-21-065517:0·
Ideal exit: 13 Aug 2022 (T+270)
5 of 5 declarations
About Civik Thomas
Thomas Civik is a Director at Repare Therapeutics Inc. and Pyxis Oncology, Inc. He brings his biotechnology expertise to the board, participating in strategic decision-making for the company. His experience is essential in guiding innovation.
